Market Cap 147.07M
Revenue (ttm) 259.05M
Net Income (ttm) -675.16M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -260.63%
Debt to Equity Ratio 0.00
Volume 54,000
Avg Vol 59,968
Day's Range N/A - N/A
Shares Out 15.32M
Stochastic %K 88%
Beta 1.11
Analysts Sell
Price Target $11.21

Latest News on AMWL

Amwell CFO Mark Hirschhorn Expands Leadership Role

Dec 18, 2024, 4:30 PM EST - 4 weeks ago

Amwell CFO Mark Hirschhorn Expands Leadership Role


American Well Corporation (AMWL) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 10:30 PM EDT - 2 months ago

American Well Corporation (AMWL) Q3 2024 Earnings Call Transcript


Amwell to participate in upcoming investor conferences

Oct 28, 2024, 7:00 AM EDT - 2 months ago

Amwell to participate in upcoming investor conferences


Amwell announces new chief financial officer

Oct 15, 2024, 4:30 PM EDT - 3 months ago

Amwell announces new chief financial officer


Amwell to report third quarter 2024 operating results

Oct 15, 2024, 7:05 AM EDT - 3 months ago

Amwell to report third quarter 2024 operating results


Amwell to Participate in Upcoming Investor Conferences

Aug 22, 2024, 4:05 PM EDT - 5 months ago

Amwell to Participate in Upcoming Investor Conferences


Amwell Beats Q2 Expectations on Subscription Revenue Strength

Jul 31, 2024, 8:02 PM EDT - 6 months ago

Amwell Beats Q2 Expectations on Subscription Revenue Strength


Amwell Announces Results for Second Quarter 2024

Jul 31, 2024, 4:05 PM EDT - 6 months ago

Amwell Announces Results for Second Quarter 2024


Amwell® to Report Second Quarter 2024 Operating Results

Jul 17, 2024, 7:00 AM EDT - 6 months ago

Amwell® to Report Second Quarter 2024 Operating Results


Amwell Announces Reverse Stock Split

Jun 28, 2024, 7:00 AM EDT - 7 months ago

Amwell Announces Reverse Stock Split


Amwell® to Report First Quarter 2024 Operating Results May 1

Apr 17, 2024, 7:00 AM EDT - 9 months ago

Amwell® to Report First Quarter 2024 Operating Results May 1


Amwell Receives Continued Listing Standard Notice From NYSE

Apr 4, 2024, 4:05 PM EDT - 10 months ago

Amwell Receives Continued Listing Standard Notice From NYSE


Amwell Names Cynthia Horner, M.D., Chief Medical Officer

Feb 22, 2024, 6:00 AM EST - 11 months ago

Amwell Names Cynthia Horner, M.D., Chief Medical Officer


Amwell to Participate in Upcoming Investor Conference

Feb 21, 2024, 6:00 AM EST - 11 months ago

Amwell to Participate in Upcoming Investor Conference


Amwell Executives to Take the Stage at ViVE 2024

Feb 15, 2024, 6:00 AM EST - 1 year ago

Amwell Executives to Take the Stage at ViVE 2024


SilverCloud by Amwell Earns Three International Awards

Jan 18, 2024, 8:00 AM EST - 1 year ago

SilverCloud by Amwell Earns Three International Awards


Amwell Announces Results for Third Quarter 2023

Nov 1, 2023, 4:05 PM EDT - 1 year ago

Amwell Announces Results for Third Quarter 2023


Amwell® to Participate in Key HLTH 2023 Engagements

Oct 4, 2023, 7:00 AM EDT - 1 year ago

Amwell® to Participate in Key HLTH 2023 Engagements


Amwell Announces Results for Second Quarter 2023

Aug 2, 2023, 4:05 PM EDT - 1 year ago

Amwell Announces Results for Second Quarter 2023


Amwell Announces Results for First Quarter 2023

May 3, 2023, 4:05 PM EDT - 1 year ago

Amwell Announces Results for First Quarter 2023